MedPath

The effect of cognitive behaviour therapy on central activation failure in Chronic Fatigue Syndrome

Conditions
chronisch vermoeidheidssyndroom
Chronic fatigue
Chronic fatigue syndrome
Registration Number
NL-OMON33070
Lead Sponsor
niversitair Medisch Centrum Sint Radboud
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
30
Inclusion Criteria

- CDC-criteria for CFS
- starting cognitive behaviour therapy
- female

Exclusion Criteria

- self-reported functional limitations of the arm or schoulder

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>Slope of Central Activation Failure (CAF) , Muscle Fibre Conduction Velocity<br /><br>(MFCV) and Maximal Voluntary Force (MVF) during the two-minute MVC before and<br /><br>after CBT.<br /><br>Successful therapy, defined as a score on the subscale fatigue of the CIS <35<br /><br>and a total score on the SIP < 700</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>Slope of the MVF during the two minute MVC before and after CBT. MVF is the<br /><br>Maximal Voluntary Force (N) of the m. biceps brachii.<br /><br>Slope of the MFCV during the two minute MVC before and after CBT: MFCV is the<br /><br>Muscle Fibre Conduction Velocity (m/s) of the nerve to the m. biceps brachii.<br /><br>(sidebranch n. musculocutaneus)</p><br>
© Copyright 2025. All Rights Reserved by MedPath